HCA co-founder Aviv Regev to lead Genentech Research and Early Development
Image credit:
Aviv stated, “While this development represents a major transition for me personally, with an opportunity to have an even deeper impact on understanding human biology and bringing therapies to patients, it will in no way diminish my involvement and roles with HCA.”
In addition to her role as Executive VP for gRED, Aviv will serve on the Corporate Executive Committee at Roche. She will be based in South San Francisco.